Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
Evaluate the safety and tolerability of AMG 427 in adult subjects with relapsed/refractory AML. Estimate the maximum tolerated dose (MTD) and / or a biologically optimal dose (eg, recommended phase 2 dose [RP2D]). Approximately 80 subjects will be enrolled.
Epistemonikos ID: 271f2b8a0b377a82c98f1f1a23433e4f9c1ee414
First added on: Jan 21, 2022